SUPN — SUPERNUS PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in SUPERNUS PHARMACEUTICALS INC (SUPN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.13% (2018 Q4)
Avg. % of fund
0.04%
First filed
2018 Q4
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 57,700 +29,359 +103.6% 0.02% $2.9M $49.70
2025 Q3 ADDED 28,341 +8,341 +41.7% 0.01% $1.4M $47.79
2024 Q2 UNCHANGED 20,000 — 0% 0.01% $535K $26.75
2024 Q1 REDUCED 20,000 -30,000 -60.0% 0.01% $682K $34.11
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SUPN price (monthly, adj. close)

Other funds also holding SUPN

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 5.5% ASHFORD CAPITAL MANAGEMENT INC 3Y 7Y 3.39% Catalio Capital Management, LP 2.26% Quantedge Capital Pte Ltd 3Y 2.12% THIRD AVENUE MANAGEMENT LLC 3Y 7Y 1.71% Villanova Investment Management Co LLC 1.68% ARMISTICE CAPITAL, LLC 3Y 7Y 1.63% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 1.28% Bruce & Co., Inc. 3Y 7Y 1.27% Sofinnova Investments, Inc. 3Y 7Y 1.19%
← Back to Caption Management, LLC Holdings